http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103040863-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2be8060f52bf7051710613dd1e9a80ca |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate | 2012-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a2e1016f46c9f51e3ee6979c450c88 |
| publicationDate | 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103040863-B |
| titleOfInvention | Disodium clodronate liposome injection |
| abstract | The invention discloses disodium clodronate liposome injection and a preparation method thereof. The disodium clodronate liposome injection with excellent quality is made of disodium clodronate, distearoyl phosphatidyl glycerol, cholesterol, polyoxyethylene (40) hydrogenated castor oil according to specific weight ratio. Compared with the existing preparation, the injection has the advantages that the stability and the bioavailability of the injection are greatly improved, drug release is stable, the quality of injection products is improved, the toxic and side effect is reduced, and the curative effect is more obvious. |
| priorityDate | 2012-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.